NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept
In Brief: NCI Grants Get More Money, Pay Line Boosted To 193
For R01s, 195 or P01s Center Funds Up By $600,000
DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board
NCI Continues Making Improvements In Contract Management
Shubik Warns NCA Members They May Be Prober’s Next Target
FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Galleri MCD vote: What FDA asked its advisors to ignore
